AUG 14, 2024 3:00 PM EDT
The Molecular Twin Platform: A multi-omic approach for predicting accurate clinical outcomes
Speaker
Abstract
The Molecular Twin is a proof-of-principle platform that combines data from several clinical and molecular analytes from both tumor and host and applies AI and machine learning approaches to identify specific multi-omic biomarker panels which are highly predictive of disease survival outcome. When used in surgically resected pancreatic ductal adenocarcinoma (PDAC), the platform established a model which best predicted survival in patients as well as generated multiple models with significantly better predictive performance than the current PDAC marker of CA 19-9. This event will also cover how these models can both be implemented in resource-poor areas and similarly generated for additional types of cancer.
Webinar agenda:
- Review precision medicine in the current landscape of single-omics
- Extend precision medicine to multi-omics
- Discuss how AI and Multi-omics can improve clinical testing and care
- Investigate the future of multi-omics and machine learning
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...